Sec. 2036. HIGH-RISK, HIGH-REWARD RESEARCH
491 words·~2 min read·
/statute-compilations/comps-13005/sec-2036A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 2036 HIGH-RISK, HIGH-REWARD RESEARCH ###
(a)In general Section 402 of the Public Health Service Act (42 U.S.C. 282), as amended by section 2031, is further amended by adding at the end the following: > > ### “(n) Unique Research Initiatives > > > #### “(1) In general > > The Director of NIH may approve, after consideration of a proposal under paragraph (2)(A), requests by the national research institutes and centers, or program officers within the Office of the Director to engage in transactions other than a contract, grant, or cooperative agreement with respect to projects that carry out— > > > ##### “(A) > > the Precision Medicine Initiative under section 498E; or > > > ##### “(B) > > section 402(b)(7), except that not more than 50 percent of the funds available for a fiscal year through the Common Fund under section 402A(c)(1) for purposes of carrying out such section 402(b)(7) may be used to engage in such other transactions. > > > #### “(2) Requirements > > The authority provided under this subsection may be used to conduct or support high impact cutting-edge research described in paragraph
(1)using the other transactions authority described in such paragraph if the institute, center, or office— > > > ##### “(A) > > submits a proposal to the Director of NIH for the use of such authority before conducting or supporting the research, including why the use of such authority is essential to promoting the success of the project; > > > ##### “(B) > > receives approval for the use of such authority from the Director of NIH; and > > > ##### “(C) > > for each year in which the institute, center, or office has used such authority in accordance with this subsection, submits a report to the Director of NIH on the activities of the institute, center, or office relating to such research.” > . ###
(b)Report to congress Not later than September 30, 2020, the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, shall conduct an evaluation of the activities under subsection
(n)of section 402 of the Public Health Service Act (42 U.S.C. 282), as added by subsection (a), and submit a report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on the results of such evaluation. ###
(c)Duties of Directors of Institutes Section 405(b)(1) of the Public Health Service Act (42 U.S.C. 284(b)(1)) is amended— ####
(1)by redesignating subparagraphs
(C)through
(L)as subparagraphs
(D)through (M), respectively; and ####
(2)by inserting after subparagraph (B), the following: > > ##### “(C) > > shall, as appropriate, conduct and support research that has the potential to transform the scientific field, has inherently higher risk, and that seeks to address major current challenges;” > .
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources